Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-26T19:50:14.543Z Has data issue: false hasContentIssue false

Outcomes of Surgically Treated Giant Pituitary Tumours

Published online by Cambridge University Press:  02 December 2014

Michael D. Cusimano*
Affiliation:
Division of Neurosurgery, Department of Laboratory Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
Peter Kan
Affiliation:
Division of Neurosurgery, Department of Laboratory Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
Farshad Nassiri
Affiliation:
Division of Neurosurgery, Department of Laboratory Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
Jennifer Anderson
Affiliation:
Department of Surgery, Department of Otorhinolaryngology, Department of Laboratory Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
Jeannette Goguen
Affiliation:
Division of Endocrinology, Department of Laboratory Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
Irene Vanek
Affiliation:
Department of Medicine, Department of Laboratory Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
Harley S. Smyth
Affiliation:
Division of Neurosurgery, Department of Laboratory Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
Ronald Fenton
Affiliation:
Department of Surgery, Department of Otorhinolaryngology, Department of Laboratory Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
Paul J. Muller
Affiliation:
Division of Neurosurgery, Department of Laboratory Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
Kalman Kovacs
Affiliation:
Division of Pathology, Department of Laboratory Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
*
Division of Neurosurgery, St. Michael's Hospital, 30 Bond Street, Toronto, Ontario, M5B 1W8, Canada. Email: injuryprevention@smh.ca
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

To evaluate the outcomes of patients with giant pituitary tumours (GPTs) who underwent a purely binasal endoscopic transsphenoidal surgery (BETS) and compare their outcomes with those achieved through craniotomy and microscopic transsphenoidal surgery (MTS).

Methods:

Seventy-two consecutive patients with GPTs (greater than 10 cm3 in volume) who were treated surgically with BETS, craniotomy, or MTS from October 1994 to July 2009 were reviewed for clinical outcomes, degree of tumor resection, recurrence rates, and surgical complications.

Results:

The BETS group had significantly better mean reduction of tumor volume (91%) than the craniotomy (63%, p = 0.001), and the MTS (63%, p = 0.010) groups. Gross total resection rates were also higher for BETS patients than for craniotomy patients (p = 0.010). Improvements in vision and headaches were noted in 96% and 100% of patients in the BETS group, respectively; these rates were similar to those in the craniotomy and MTS groups. Of the four patients with hormone-secreting tumours in the BETS group, three remained in remission. The median length-of-stay (four days) for the BETS group was shorter (p = 0.010), and surgical complications were less frequent (p = 0.037) and less severe compared to the craniotomy group. There were no differences in the recurrence rates: 79% percent of patients in the BETS group, 69% in the craniotomy group, and 79% in the MTS group were recurrence free at last follow-up (p = 0.829).

Conclusions:

Treatment of GPT with BETS offers excellent oncologic and clinical outcomes and can frequently obviate the need for craniotomy in these patients.

Type
Original Article
Copyright
Copyright © The Canadian Journal of Neurological 2012

References

1.Garibi, J, Pomposo, I, Villar, G, Gaztambide, S.Giant pituitary adenomas: clinical characteristics and surgical results. Br J Neurosurg. 2002 Apr;16(2):1339.Google Scholar
2.Goel, A, Nadkarni, T, Muzumdar, D, Desai, K, Phalke, U, Sharma, P.Giant pituitary tumours: a study based on surgical treatment of 118 cases. Surg Neurol. 2004 May;61(5):43645; discussion 45-6.CrossRefGoogle ScholarPubMed
3.Mortini, P, Barzaghi, R, Losa, M, Boari, N, Giovanelli, M.Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients. Neurosurgery. 2007 Jun;60(6):9931002; discussion 3-4.CrossRefGoogle Scholar
4.Fisher, BJ, Gaspar, LE, Noone, B.Giant pituitary adenomas: role of radiotherapy. Int J Radiat Oncol Biol Phys. 1993 Mar 15;25(4):67781.Google Scholar
5.Krisht, AF.Giant invasive pituitary adenomas: management plan. Contemp Neurosurg. 1999;21:16.Google Scholar
6.Laws, ER, Jane, JA Jr. Neurosurgical approach to treating pituitary adenomas. Growth Horm IGF Res. 2005 Jul;15 Suppl A:S3641.CrossRefGoogle ScholarPubMed
7.Jane, JA Jr., Laws, ER Jr. The surgical management of pituitary adenomas in a series of 3,093 patients. J Am Coll Surg. 2001 Dec;193(6):6519.Google Scholar
8.King, WA, Rodts, GE, Becker, DP, Mc Bride, DQ.Microsurgical Management of Giant Pituitary Tumours. Skull Base Surg. 1996;6(1):1726.Google Scholar
9.Ciric, I, Mikhael, M, Stafford, T, Lawson, L, Garces, R.Trans-sphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results. J Neurosurg. 1983 Sep;59(3):395401.CrossRefGoogle Scholar
10.Jefferson, G.Extrasellar Extensions of Pituitary Adenomas: (Section of Neurology). Proc R Soc Med. 1940 May;33(7):43358.Google Scholar
11.Nakane, T, Kuwayama, A, Watanabe, M.Transsphenoidal approach to pituitary adenomas with suprasellar extension. Surg Neurol. 1981;16:2259.Google Scholar
12.Wilson, CB.Neurosurgical management of large and invasive pituitary tumours. In: Tindall, FT, Collins, WF, editors. Clinical Management of Pituitary Disorders. New York: Raven Press; 1979. p.35542.Google Scholar
13.Bakay, L.The results of 300 pituitary adenoma operations (Prof. Herbert Olivecrona’s series). J Neurosurg. 1950 May;7(3):24055.Google Scholar
14.Mohr, G, Hardy, J, Comtois, R, Beauregard, H.Surgical management of giant pituitary adenomas. Can J Neurol Sci. 1990 Feb;17(1):626.CrossRefGoogle ScholarPubMed
15.Symon, L, Jakubowski, J, Kendall, B.Surgical treatment of giant pituitary adenomas. J Neurol Neurosurg Psychiatry. 1979 Nov;42(11):97382.Google Scholar
16.Pia, HW, Grote, E, Hildebrand, G.Giant pituitary adenomas. Neurosurg Rev. 1985;8(3-4):20720.CrossRefGoogle ScholarPubMed
17.Xue-Fei, S, Yong-Fei, W, Shi-Qi, L, et al.Microsurgical treatment for giant and irregular pituitary adenomas in a series of 54 consecutive patients. Br J Neurosurg. 2008 Oct;22(5):63648.CrossRefGoogle Scholar
18.Goel, A, Nadkarni, T.Surgical management of giant pituitary tumours-a review of 30 cases. Acta Neurochir (Wien). 1996;138(9):10429.CrossRefGoogle ScholarPubMed
19.Jefferson, A.Chromophobe pituitary adenomata the size of the suprasellar portion in relation to the safety of operation (Abstract). J Neurol Neurosurg Psychiatry. 1969;32:633.Google Scholar
20.Cavallo, LM, de Divitiis, O, Ay din, S, et al.Extended endoscopic endonasal transsphenoidal approach to the suprasellar area: anatomic considerations-part 1. Neurosurgery. 2008 Jun;62(6 Suppl 3):120212.CrossRefGoogle Scholar
21.Chacko, G, Chacko, AG, Lombardero, M, et al.Clinicopathologic correlates of giant pituitary adenomas. J Clin Neurosci. 2009 May;16(5):6605.Google Scholar
22.Tsang, RW, Brierley, JD, Panzarella, T, et al.Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys. 1994 Oct 15;30(3):55765.Google Scholar
23.Tsang, RW, Brierley, JD, Panzarella, T, et al.Role of radiation therapy in clinical hormonally-active pituitary adenomas. Radiother Oncol. 1996 Oct;41(1):4553.Google Scholar
24.Jho, HD, Carrau, RL, Ko, Y, Daly, MA.Endoscopic pituitary surgery: an early experience. Surg Neurol. 1997 Mar;47(3):21322; discussion 22-3.Google Scholar
25.Cusimano, MD, Fenton, RS.The technique for endoscopic pituitary tumor removal. Neurosurg Focus. 1996 Jul 15;1(1):e1; discussion p following e3.Google Scholar
26.Cavallo, LM, Prevedello, DM, Solari, D, et al.Extended endoscopic endonasal transsphenoidal approach for residual or recurrent craniopharyngiomas. J Neurosurg. 2009 Sep;111(3):57889.Google Scholar
27.de Notaris, M, Cavallo, LM, Prats-Galino, A, et al.Endoscopic endonasal transclival approach and retrosigmoid approach to the clival and petroclival regions. Neurosurgery. 2009 Dec;65(6 Suppl):4250; discussion -2.Google Scholar
28.Ceylan, S, Koc, K, Anik, I.Extended endoscopic approaches for midline skull-base lesions. Neurosurg Rev. 2009 Jul;32(3):30919; discussion 18-9.CrossRefGoogle ScholarPubMed
29.AAlahmadi, H, Vachhrajani, S, Cusimano, MD.The natural history of brain contusion: an analysis of radiological and clinical progression. J Neurosurg. 2010;112(5):113945.Google Scholar
30.Kong, DS, Lee, JI, Lim do, H, et al.The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. Cancer. 2007 Aug 15;110(4):85460.Google Scholar
31.Shamim, MS, Bari, ME, Khursheed, F, Jooma, R, Enam, SA.Pituitary adenomas: presentations and outcomes in a South Asian country. Can J Neurol Sci. 2008 May;35(2):198203.Google Scholar
32.Shin, KH, Moon, SH, Suh, JS, Yang, WI.Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma. Clin Orthop Relat Res. 2000 Jul(376):2008.Google Scholar
33.Vieira, JO Jr., Cukiert, A, Liberman, B.Evaluation of magnetic resonance imaging criteria for cavernous sinus invasion in patients with pituitary adenomas: logistic regression analysis and correlation with surgical findings. Surg Neurol. 2006 Feb;65(2):1305; discussion 5.CrossRefGoogle ScholarPubMed
34.Bahmer, FA, Hantirah, S, Baum, HP.Rapid and unbiased estimation of the volume of cutaneous malignant melanoma using Cavalieri’s principle. Am J Dermatopathol. 1996 Apr;18(2):15964.Google Scholar
35.Knosp, E, Steiner, E, Kitz, K, Matula, C.Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. 1993 Oct;33(4):6107; discussion 7-8.Google ScholarPubMed
36.Hardy, J.Transphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg. 1969;16:185217.CrossRefGoogle ScholarPubMed
37.Youssef, AS, Agazzi, S, van Loveren, HR.Transcranial surgery for pituitary adenomas. Neurosurgery. 2005 Jul;57(1 Suppl):16875; discussion -75.Google ScholarPubMed
38.de Notaris, M, Esposito, I, Cavallo, LM, et al.Endoscopic endonasal approach to the ethmoidal planum: anatomic study. Neurosurg Rev. 2008 Jul;31(3):30917.Google Scholar
39.Aydin, S, Cavallo, LM, Messina, A, et al.The endoscopic endonasal trans-sphenoidal approach to the sellar and suprasellar area. Anatomic study. J Neurosurg Sci. 2007 Sep;51(3):12938.Google Scholar
40.de Divitiis, E, Cavallo, LM, Cappabianca, P, Esposito, F.Extended endoscopic endonasal trans sphenoidal approach for the removal of suprasellar tumours: Part 2. Neurosurgery. 2007 Jan;60(1):4658; discussion -9.Google Scholar
41.Laufer, I, Anand, VK, Schwartz, TH.Endoscopic, endonasal extended trans sphenoidal, transplanum transtuberculum approach for resection of suprasellar lesions. J Neurosurg. 2007 Mar;106(3):4006.CrossRefGoogle Scholar
42.Alleyne, CH Jr., Barrow, DL, Oyesiku, NM.Combined trans sphenoidal and pterional craniotomy approach to giant pituitary tumours. Surg Neurol. 2002 Jun;57(6):38090; discussion 90.Google Scholar
43.de Divitiis, E.Endoscopic transsphenoidal surgery: stone-in-the-pond effect. Neurosurgery. 2006 Sep;59(3):51220; discussion -20.Google Scholar
44.Kabil, MS, Eby, JB, Shahinian, HK.Fully endoscopic endonasal vs. transseptal transsphenoidal pituitary surgery. Minim Invasive Neurosurg. 2005 Dec;48(6):34854.Google Scholar
45.Cappabianca, P, Alfieri, A, Colao, A, Ferone, D, Lombardi, G, de Divitiis, E.Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions. Skull Base Surg. 1999;9(2):10917.CrossRefGoogle ScholarPubMed
46.Rudnik, A, Zawadzki, T, Galuszka-Ignasiak, B, et al.Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas-first experience. Minim Invasive Neurosurg. 2006 Feb;49(1):104.Google Scholar
47.Ebersold, MJ, Quast, LM, Laws, ER Jr., Scheithauer, B, Randall, RV.Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg. 1986 May;64(5):7139.Google Scholar
48.Horvath, E, Kovacs, K, Smyth, HS, Cusimano, M, Singer, W.Silent adenoma subtype 3 of the pituitary-immunohistochemical and ultrastructural classification: a review of 29 cases. Ultrastruct Pathol. 2005 Nov-Dec;29(6):51124.Google Scholar
49.Sanno, N, Teramoto, A, Osamura, RY.Clinical and cytofunctional classification of pituitary adenomas: proposal of a new classification. Acta Neurochir (Wien). 1996;138(10):118692.CrossRefGoogle ScholarPubMed
50.Selch, MT, Gorgulho, A, Lee, SP, et al.Stereotactic radiotherapy for the treatment of pituitary adenomas. Minim Invasive Neurosurg. 2006 Jun;49(3):1505.CrossRefGoogle ScholarPubMed
51.Fisher, BJ, Gaspar, LE, Noone, B.Radiation therapy of pituitary adenoma: delayed sequelae. Radiology. 1993 Jun;187(3):8436.Google Scholar
52.Littley, MD, Shalet, SM, Beardwell, CG, Robinson, EL, Sutton, ML.Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol (Oxf). 1989 Sep;31(3):36373.Google Scholar
53.Chang, EF, Zada, G, Kim, S, et al.Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas. J Neurosurg. 2008 Apr;108(4):73645.Google Scholar
54.de Paiva Neto, MA, Vandergrift, A, Fatemi, N, et al.Endonasal transsphenoidal surgery and multimodality treatment for giant pituitary adenomas. Clin Endocrinol (Oxf). 2010;72(4):5129.Google Scholar